Probiotic strain identities and separate material specifications
Viable-count declaration at manufacture or end of shelf life.
Oral capsules OEM/ODM
Probiotic and Xylooligosaccharide Capsules
An oral capsule direction combining a probiotic brief with xylooligosaccharide (XOS). Keep both components in the procurement specification while discussing strain identity, viable-count basis, XOS material and capsule packaging. This direction does not imply a fixed strain blend or a health outcome.
Probiotic and Xylooligosaccharide Capsules project specifications
Prepare a project brief for quotation. Formula, packaging and commercial terms are agreed for the individual project.
- Dosage form
- Hard Capsule
- Common specification
- Ingredient declarations and per-unit or per-serving basis agreed by project.
- Pack count
- Reference configuration: 60 Capsules. Final pack size agreed by project.
- Packaging
- Bottle illustration; final packaging agreed by project.
- MOQ & quotation
- Product-specific project quotation
- Target market
- Destination-market requirements to review
Formula direction for discussion
An oral capsule direction combining a probiotic brief with xylooligosaccharide (XOS). Keep both components in the procurement specification while discussing strain identity, viable-count basis, XOS material and capsule packaging. This direction does not imply a fixed strain blend or a health outcome. Discuss: Probiotic strain identities and separate material specifications; Viable-count declaration at manufacture or end of shelf life; Xylooligosaccharide specification and proposed amount; Capsule shell, moisture protection and storage discussion; Serving basis, stability and destination-market ingredient review.
Manufacturing capability does not establish a fixed formula, certification, allergen status or destination-market approval. Reference packaging is not a daily-use recommendation.
Custom Formula & Private Label
An oral capsule direction combining a probiotic brief with xylooligosaccharide (XOS). Keep both components in the procurement specification while discussing strain identity, viable-count basis, XOS material and capsule packaging. This direction does not imply a fixed strain blend or a health outcome.
Product direction overview
Probiotic and Xylooligosaccharide Capsules as a B2B OEM/ODM product direction
An oral capsule direction combining a probiotic brief with xylooligosaccharide (XOS). Keep both components in the procurement specification while discussing strain identity, viable-count basis, XOS material and capsule packaging. This direction does not imply a fixed strain blend or a health outcome.
Prepare your Probiotic and Xylooligosaccharide Capsules brief
Include the requested materials, individual declarations, serving basis, packaging and destination market for Probiotic and Xylooligosaccharide Capsules.
Discuss Probiotic and Xylooligosaccharide Capsules OEM/ODM project details
Include the requested materials, individual declarations, serving basis, packaging and destination market for Probiotic and Xylooligosaccharide Capsules.
OEM/ODM support scope
How Bodakang Bio supports project coordination
Bodakang Bio helps buyers structure product discussions before quotation, sample review and order coordination.
Formulation discussion
Xylooligosaccharide specification and proposed amount. Capsule shell, moisture protection and storage discussion.
Project requirements
Serving basis, stability and destination-market ingredient review.
Product documents & market review
Discuss the product-specific specification, analytical requirements, material documents and destination-market label review. No report, certificate or approval is implied before its scope is checked.
Suitable dosage form
Capsules project format
An oral capsule direction combining a probiotic brief with xylooligosaccharide (XOS). Keep both components in the procurement specification while discussing strain identity, viable-count basis, XOS material and capsule packaging. This direction does not imply a fixed strain blend or a health outcome.
Private label customization
Customization directions for discussion
Final customization depends on confirmed formula, dosage form, package type, quantity and target market requirements.
Probiotic strain identities and separate material specifications
Viable-count declaration at manufacture or end of shelf life
Xylooligosaccharide specification and proposed amount
Capsule shell, moisture protection and storage discussion
Serving basis, stability and destination-market ingredient review
Packaging options
Packaging details to prepare
Packaging can be discussed after product direction, dosage form and quantity range are clearer.
Bottle format for suitability review
Final pack size, closure and artwork to agree
Destination-market label language
Secondary packaging and transport requirements
Suitable buyer types
Who this product direction is for
These pages are written for B2B buyers preparing OEM/ODM and private label project discussions.
Supplement brands
Private label operators
Importers and distributors
Project process
How product detail discussions move forward
The process keeps buyer requirements, formula direction, packaging needs and document discussion organized before production coordination.
01
Submit material requirements and intended market
02
Review the ingredient and dosage-form brief
03
Discuss packaging and sample scope
04
Agree specifications and product-specific quotation
05
Coordinate the confirmed production order
Formula discussion
Formulation discussion
Bring your specification or describe the product direction you need.
- Probiotic strain identities and separate material specifications
- Viable-count declaration at manufacture or end of shelf life
- Xylooligosaccharide specification and proposed amount
- Capsule shell, moisture protection and storage discussion
- Serving basis, stability and destination-market ingredient review
Project quotation
MOQ, samples & production timing
Commercial terms are confirmed for the agreed project scope.
MOQ and quotation: confirmed for the proposed formula, packaging and order quantity.
Samples: availability, scope, fees and timing are agreed for the individual project.
Production lead time: reviewed after the specification, packaging and order requirements are defined.
Buyer FAQ
Buyer questions
Prepare the product and commercial brief before sampling and order confirmation.
Is XOS the same as the probiotic component?
No. Xylooligosaccharide (XOS) is specified separately from the probiotic materials. Keep strain identities, viable counts and the XOS quantity distinct in the project brief.
Are probiotic strains and CFU guaranteed by this page?
No fixed strains or viable counts are offered here. Discuss strain identification, analytical method, storage and whether a count applies at manufacture or at the end of shelf life.
What does 60 Capsules represent?
It is a reference bottle configuration, not a confirmed stock SKU or a daily-use recommendation. The capsule count and serving basis are agreed for the proposed product.
Is this an oral product or an external-use capsule?
This project direction is an oral nutrition supplement capsule. It is not an external-use cosmetic or an intravaginal product, and no treatment or other health claim is made.
What packaging can be discussed for this product?
Bottle presentation, closure, artwork, final pack size and transport requirements can be reviewed. 60 Capsules is a reference packaging configuration for discussion. Final formula, specification and packaging are agreed by project.
How are samples, MOQ and quotations arranged?
Send the ingredient specifications, intended market, proposed packaging and order quantity. Sample availability, fees and timing, MOQ, quotation and production lead time are confirmed for the individual project.
Related product directions
Continue exploring related support pages
Use these pages to compare dosage forms, adjacent product directions and broader private label support options.